Amlodipine as a Novel Anticancer Agent for Triple Negative Breast Cancer via HV-1 Ion Channel Inhibition

PK202600766A0Pending Publication Date: 2026-09-10AMBER ILYAS +2

0 Cites 0 Cited by

Patent Information

Application Number: PK202600766
Authority / Receiving Office: PK · PK
Patent Type: Applications
Current Assignee / Owner
Filing Date: 2026-08-24
Publication Date: 2026-09-10

Patent Text Reader

Need to check novelty before this filing date? Find Prior Art

No text content released.